Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.
According to the World Health Organization, 360 million people worldwide, including 32 million children, suffer from hearing loss caused by congenital defects or other factors. These factors include infectious disease, use of certain medicines, or exposure to excessive noise. Yet, there are currently no FDA-approved drugs to prevent or treat hearing loss.
A team of researchers led by Dr. Jian Zuo screened over 4,000 drugs for their ability to protect cochlear cells from the chemotherapy agent cisplatin. Cisplatin is used to treat a variety of cancers but causes irreversible hearing loss in up to 70% of patients.
Zuo and colleagues identified multiple compounds that protected cochlear cells from cisplatin, several of which are already approved to treat other conditions. Three of the ten most effective compounds were inhibitors of an enzyme called CDK2. One of these CDK2 inhibitors, kenpaullone, was more effective than four other compounds that are currently in clinical trials for treating hearing loss.
Injecting kenpaullone into the middle ear protected both mice and rats from cisplatin-induced hearing loss. Moreover, kenpaullone also protected the hearing of mice to noise as loud as 100 dB. “Given that 100-dB noise is in the range of noise insults commonly experienced by people in our society, kenpaullone could have significant clinical application in treating noise-induced hearing loss,” says Zuo.
In the case of cisplatin-induced hearing loss, kenpaullone appears to protect hair cells by preventing CDK2 from stimulating the production of toxic reactive oxygen species from the cells’ mitochondria.
“The robust protection conferred by one-time local delivery of kenpaullone suggests that CDK2 inhibitors may transform the clinical prevention and treatment of cisplatin- and noise-induced hearing loss in patients,” Zuo says. “Modifications of the treatment regimens, additional optimization of the delivery methods via the use of hydrogels, and structural modifications of the compounds via medicinal chemistry could ensure even better results with CDK2 inhibitors in treating hearing loss in humans.”
Learn more:Â Researchers identify new drugs that could help prevent hearing loss
The Latest on: Hearing loss
[google_news title=”” keyword=”Hearing loss” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hearing loss
- More children gain hearing as gene therapy for profound deafness advanceson May 10, 2024 at 3:08 pm
Enlarge / Opal Sandy (center), who was born completely deaf because of a rare genetic condition, can now hear unaided for the first time after receiving gene therapy at 11-months-old. She is shown ...
- UK toddler regains hearing in gene therapy breakthroughon May 10, 2024 at 12:03 pm
STORY: Banging on blocks and playing the flute, Opal Sandy looks like an average energetic toddler. :: May 1, 2024It would be hard to tell she was born deaf - and unable to hear just months earlier. : ...
- Clinical practice guideline developed for age-related hearing losson May 10, 2024 at 10:46 am
The recommendations include identification of sociodemographic factors and patient preferences that influence access to and use of hearing healthcare.
- Studies suggest hearing loss and dementia may be connectedon May 10, 2024 at 3:11 am
LETHBRIDGE [email protected] jury may still be out, but research seems to indicate hearing loss and cognitive health is likely ...
- PIP or ADP could help people with hearing loss by providing up to £737 each monthon May 10, 2024 at 2:01 am
Deaf Awareness Week runs until May 12 and is an annual event aimed at promoting understanding and raising awareness on the challenges faced by people with hearing loss issues. According to the latest ...
- Hidden Hearing Loss Linked to Tinnitus, Harvard Study Findson May 10, 2024 at 12:40 am
Tinnitus, a condition characterized by a persistent ringing or whining sound in the ears, affects between 10 to 25 percent of adults globally, according to the World Health Organization (WHO). Despite ...
- Woman with partial hearing loss shares experiences for Deaf Awareness Weekon May 9, 2024 at 10:08 pm
However, it was not always so easy for Ms Hutchins-Lee to manage her hearing loss. Seven years ago, after a struggle to hear her young son talk led to multiple GP appointments and hospital tests, she ...
- Talking hearing loss and aging with the University of Minnesotaon May 9, 2024 at 5:13 am
MINNEAPOLIS — Many Minnesotans experience changes to hearing and speech as they age. One-third of adults over 65 have hearing loss that significantly affects their lives. University of Minnesota ...
- Kyians experiencing hearing loss encouraged to act during Better Hearing and Speech Month in Mayon May 8, 2024 at 9:40 pm
With approximately 700,000 Kentuckians of all ages experiencing some degree of hearing loss, Gov. Andy Beshear and the Kentucky Commission on the Deaf and Hard of Hearing are encouraging people to ...
- Hearing Dogs: How They Alert and Assist Individuals with Hearing Losson May 5, 2024 at 8:23 pm
Hearing loss is a common health issue that affects millions of people worldwide. Individuals with hearing loss often face a variety of challenges in their daily lives, including difficulties in ...
via Bing News